DonnyAdmin's Profile
DonnyAdmin's Posts
Re: TRADING ALERT: KWESST Micro Systems (KWE: TSX-V) (KWEMF: OTCQB) Up 16% On 478K Shares
replying to test
8 months
ago
DonnyAdmin
City
Vancouver
Rank
Administrator
Activity Points
43
Rating
Date Joined
06/02/2016
Followed Members
ADMINISTRATOR
Last Posted:
08/03/2022
Rating:
Messages:
19063
Followed Hubs
Symbol:
MCOA
Exchange:
PINK
Shares:
1,984,042,453
Industry:
Website:
Company is at the forefront of hemp marketing and distribution. Cannabis sales in US expected to be more than $40 Billion by 2020.
Symbol:
BFF
Exchange:
TSX-V
Shares:
93,584,171 ...
Industry:
Website:
Company owns 60 claims in Clayton Valley, Esmeralda County, Nevada, 250 meters from Albemarle Corporation’s Silver Peak lithium mine and brine processing operations. This is
also the location of Pure Energy Minerals’ 816,000 metric tonnes Lithium Carbonate Equivalent (LCE) Inferred Resource.
Symbol:
AMK
Exchange:
TSX-V
Shares:
397,190,109 ...
Industry:
Website:
American Creek owns a 20% Carried Interest to Production at the Treaty Creek Project in the Golden Triangle.
2020 best intercept of 0.856 gpt AuEq over 1033.5 meters. The Treaty Creek property is located in the same hydrothermal system as the Pretivm and Seabridge's KSM deposits.
Symbol:
GMBL
Exchange:
NAZ
Shares:
Industry:
Website:
Esports audience is 350M, growing to 590M, Esports wagering is projected at $23 BILLION by this year. The company has launched VIE.gg esports betting platform and has accelerated affiliate marketing agreements with 190 Esports teams.
Symbol:
TN
Exchange:
CSE
Shares:
112,754,829 ...
Industry:
Website:
Tartisan Nickel Corp. owns the Kenbridge Class 1 Nickel Project in northwestern Ontario. Updated Mineral Resource Estimate of 117m lbs Ni, 66m lbs Cu.
The Company has equity stakes in Eloro Resources, Class 1 Nickel, Peruvian Metals Corp. and Silver Bullet Mines.
Symbol:
TBP
Exchange:
TSX-V
Shares:
153,916,631 ...
Industry:
Website:
A biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers.